Tumor ablation is an emerging cancer therapy method that is gaining steady and wide acceptance as a
successful cancer therapeutic. Tumor ablation is a method that ensured higher efficacy of tumor cell
treatment with minimum toxicity or side effects. This form of treatment involves the destruction of
tumors using heat, low temperature and chemical agents that are introduced into the tumor regions
using a guided needle through a small hole.
Some of the significant factors driving the growth of the Global Tumor Ablation Market are
Technological advancements in the field of tumor ablation coupled with increased procedural safety
profile, rising market demand of minimal invasive tumor ablation techniques, increasing prevalence of
cancer across the globe, as well as growing number of public-private initiatives & funding to support
ongoing research activities related to tumor ablation
Boston Scientific Corporation (NYSE: BSX) announced data from the AF-FICIENT I study during a late-
breaking clinical trial session today at EHRA 2019, the annual congress of the European Heart Rhythm
Association in Lisbon, Portugal. The data demonstrated positive safety and efficacy results with the
LUMINIZE Radiofrequency (RF) Balloon Catheter for isolation of pulmonary veins (PV) when treating
patients with atrial fibrillation (AF).
Tumor Ablation Market Covers the Table of Contents With Segments, Key Players And Region. Based on
Product Type, Tumor Ablation Market is sub segmented into Radiofrequency, Microwave, Cryoablation,
IRE, Ultrasound. On the Basis of Application, Market is sub segmented into Surgical, Laparoscopic,
Percutaneous.
Request a Discount on standard prices of this premium report @
https://www.businessindustryreports.com/check-discount/162912 .
Major Players profiled in the Tumor Ablation Market report incorporate: Angiodynamics, Boston
Scientific Corporation, Galil Medical, EDAP TMS S.A, Healthtronics Inc, Medtronic, Mermaid Medical,
Mesonix, Neuwave Medical, Sonacare Medical, Canyon, ECO Medical
Region segment: This report is segmented into several key regions, with sales, revenue, market share
(%) and growth Rate (%) of Tumor Ablation in these regions, from 2014 to 2023 (forecast), covering:
North America, Europe, Asia Pacific, Middle East & Africa and South America.
The report is a compilation of first-hand information, qualitative and quantitative assessment by
industry analysts, inputs from industry experts and industry participants across the value chain. The
report provides in-depth analysis of parent market trends, macro-economic indicators and governing
factors along with market attractiveness as per segments. The report also maps the qualitative impact of
various market factors on market segments and geographies.
Significant points in table of contents: Market Definition, Market Overview, Business Introduction,
Segmentation (Region Level), Segmentation (Type Level), Segmentation (Industry Level), Segmentation
(Channel Level), Market Forecast Year, Segmentation Type, Segmentation Industry, Market Cost
Analysis, and Conclusion.